What are the criteria for a Ventilation-Perfusion (VQ) scan to suggest Chronic Thromboembolic Pulmonary Hypertension (CTEPH)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

VQ Scan Criteria for CTEPH Diagnosis

A VQ scan showing at least one segmental or larger mismatched perfusion defect is the key criterion suggesting CTEPH, while a normal or low-probability VQ scan effectively excludes the diagnosis with 90-100% sensitivity and 94-100% specificity. 1

Primary Diagnostic Criteria

The presence of segmental mismatched perfusion defects is the hallmark finding:

  • At least 2.5 segmental mismatched perfusion defects provides optimal diagnostic accuracy with 100% sensitivity and 94.7% specificity 2
  • The majority (95%) of CTEPH patients demonstrate more than 4 segmental mismatched perfusion defects 2
  • These defects appear as wedge-shaped, segmental patterns that are characteristic of chronic thromboembolic disease 1
  • The defects must be mismatched (perfusion defect without corresponding ventilation abnormality) to distinguish from other pulmonary conditions 1

Negative Predictive Value (Ruling Out CTEPH)

A normal perfusion scan is the most powerful tool for excluding CTEPH:

  • A normal or low-probability VQ scan essentially excludes CTEPH as a diagnostic consideration 1
  • This provides 90-100% sensitivity and 94-100% specificity for ruling out the disease 1
  • The negative predictive value is so high that patients with normal VQ scans are typically not offered surgery 1

Important Distinctions from Other Conditions

VQ scan patterns differ between CTEPH and other forms of pulmonary hypertension:

  • In pulmonary arterial hypertension (PAH), the VQ scan may be normal or show only small peripheral, unmatched, non-segmental defects 1
  • No patient with idiopathic PAH should have a high-probability VQ scan 1
  • Unmatched perfusion defects can also occur in pulmonary veno-occlusive disease (PVOD), creating a diagnostic caveat 1

Technical Considerations

VQ scintigraphy is superior to CT pulmonary angiography for CTEPH screening:

  • VQ scanning demonstrates 96-97% sensitivity compared to only 51% sensitivity for CT angiography 1, 3
  • This superiority is especially pronounced in centers without significant CTEPH experience 1
  • VQ SPECT (single-photon emission CT) further improves accuracy to 94% compared to planar imaging 1

Critical Clinical Pitfall

Never rely on CT alone to exclude CTEPH:

  • CT can appear relatively normal despite significant abnormalities on VQ scintigraphy 3
  • Multiple studies document cases where CT missed surgically accessible CTEPH that was detected by VQ scanning 1, 3
  • This represents a critical missed opportunity for potentially curative surgical therapy 1, 3

Guideline-Recommended Diagnostic Algorithm

The ESC/ERS guidelines establish a clear pathway:

  • VQ scanning is the mandatory first-line imaging modality for all patients with unexplained pulmonary hypertension 1, 3
  • If multiple segmental perfusion defects are present, proceed to CT pulmonary angiography for anatomic confirmation and surgical planning 3
  • Right heart catheterization provides definitive hemodynamic diagnosis and is required before treatment decisions 3
  • Pulmonary angiography is generally required to confirm surgical accessibility of chronic thromboemboli 1

Interpretation Based on Perfusion Alone

While interpretation can be based solely on perfusion defects (without ventilation imaging), this approach provides similar sensitivity but reduced specificity (81.8% versus 94.7% when ventilation is included) 2. Therefore, matched ventilation-perfusion imaging is preferred for optimal diagnostic accuracy.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Diagnostic Approach to Chronic Thromboembolic Pulmonary Hypertension

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.